TrialClinical journal of the American Society of Nephrology : CJASN2019
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.
Barbara Seitz-Polski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
86 papers cite itlatest 60 shown
this paperpooled ittrialcites it